Konstanz biologist Patrick Müller receives a Proof of Concept Grant from the European Research Council for his project "EmbryoNet-AI". Its goal is the further development of an AI-supported platform ...

This transaction adds a pipeline of early-stage drug candidates against high-value targets including DLL3[1] and integrin αvβ6[2], as well as several other novel targets in discovery stage ...

Dr. Imbert brings 25 years of strategic clinical to commercial-stage manufacturing and drug development experience SOUTH SAN FRANCISCO, Calif., Jan. 22, 2025 (GLOBE NEWSWIRE) -- Pliant Therapeutics, ...

This transaction adds a pipeline of early-stage drug candidates against high-value targets including DLL3 [1] and integrin avß6 [2], as well as several other novel targets in discovery stage ...

Investigation Discovery’s ‘The Fall of Diddy’ series airs Jan. 27-28 and will stream on Max and discovery+ at the same time.

“Looking ahead, we are excited about Cybin’s next phase of investigation and growth and for the upcoming milestones, including a readout of topline efficacy data from our CYB004 Phase 2 GAD study in ...

The new Express License service removes barriers to accessing this transformative gene editing technology for startups.An ...

We recently published a list of Complete List of All AI Companies Under $2 Billion Market Cap. In this article, we are going ...

Fast forward to today, and amid the emerging and critical Gaza ceasefire-hostage deal, Lebanon represents a vital opportunity ...

Company plans to meet with the FDA to align on registrational trial designs in 1H25 based on emerging clinical profile of resecabtagene ...